We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
WEX
WEX
$6.84B
| $59.1M | 0.15% |
324,653
-55,013
| -14% | -$9.74M |
|
177
Las Vegas Sands
LVS
$27.5B
| $58.7M | 0.15% |
1,011,417
+142,643
| +16% | +$8.44M |
|
178
Delta Air Lines
DAL
$52.5B
| $58.6M | 0.15% |
1,232,263
+64,241
| +5% | +$2.37M |
|
179
Arista Networks
ANET
$237B
| $58.1M | 0.14% |
1,433,084
-1,083,724
| -43% | -$41.9M |
|
180
Airbnb
ABNB
$101B
| $57.4M | 0.14% |
448,034
-127,345
| -22% | -$14.9M |
|
181
Teladoc Health
TDOC
$1.18B
| $57.2M | 0.14% |
2,260,147
-264,647
| -10% | -$6.66M |
|
182
Westlake Corp
WLK
$8.81B
| $57M | 0.14% |
477,144
-179
| -0% | -$20.5K |
|
183
Zentalis Pharmaceuticals
ZNTL
$331M
| $56.9M | 0.14% |
2,018,234
+531,236
| +36% | +$12.7M |
|
|
AYX
184
DELISTED
Alteryx Inc
AYX
| $56.8M | 0.14% |
1,250,000
+215,919
| +21% | +$9.46M |
|
185
Kroger
KR
$36.3B
| $56.6M | 0.14% |
1,205,009
+47,395
| +4% | +$2.26M |
|
186
Workday
WDAY
$46.8B
| $56.4M | 0.14% |
249,679
+10,351
| +4% | +$2.07M |
|
187
Matador Resources
MTDR
$7.57B
| $56.3M | 0.14% |
1,076,039
-10,775
| -1% | -$521K |
|
188
AptarGroup
ATR
$7.94B
| $55.9M | 0.14% |
482,273
-6,142
| -1% | -$720K |
|
189
Floor & Decor
FND
$5.13B
| $55.6M | 0.14% |
534,976
-45,424
| -8% | -$4.34M |
|
190
Vertex Pharmaceuticals
VRTX
$132B
| $55.4M | 0.14% |
157,448
-12,211
| -7% | -$4.11M |
|
191
Tyler Technologies
TYL
$14.7B
| $55.1M | 0.14% |
132,357
-259
| -0.2% | -$99.7K |
|
192
Reinsurance Group of America
RGA
$16.3B
| $55.1M | 0.14% |
397,366
-9,368
| -2% | -$1.33M |
|
193
SLB Ltd
SLB
$79.1B
| $55M | 0.14% |
1,120,680
-84,607
| -7% | -$4.03M |
|
194
Seres Therapeutics
MCRB
$47.5M
| $54.6M | 0.14% |
569,740
-194,128
| -25% | -$21.1M |
|
195
Insulet
PODD
$9.56B
| $54.5M | 0.14% |
188,956
+13,863
| +8% | +$4.21M |
|
196
Sportradar
SRAD
$3.9B
| $54.1M | 0.13% |
4,194,034
+748,844
| +22% | +$9.03M |
|
197
Lamb Weston
LW
$6.63B
| $53.8M | 0.13% |
468,431
+152,294
| +48% | +$17M |
|
198
Woodward
WWD
$19.2B
| $53.4M | 0.13% |
448,719
-39,094
| -8% | -$4.14M |
|
199
Agilent Technologies
A
$41.4B
| $53.3M | 0.13% |
443,097
+32,590
| +8% | +$4.15M |
|
200
ATI
ATI
$25.6B
| $52.8M | 0.13% |
1,193,704
+68,315
| +6% | +$2.61M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.